Evidence map›Paper›PMID 25028888›Full record

ArticleBiophysical journal2014

Explaining the non-newtonian character of aggregating monoclonal antibody solutions using small-angle neutron scattering.

Maria Monica Castellanos, Jai A Pathak, William Leach, Steven M Bishop, Ralph H Colby

Abstract read
In one paragraph

Article in Biophysical journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria Monica CastellanosDepartment of Materials Science and Engineering, The Pennsylvania State University, University Park, Pennsylvania.
Jai A PathakFormulation Sciences Department, MedImmune, Gaithersburg, Maryland. Electronic address: PathakJ@medimmune.com.
William LeachFormulation Sciences Department, MedImmune, Gaithersburg, Maryland.
Steven M BishopFormulation Sciences Department, MedImmune, Gaithersburg, Maryland.
Ralph H ColbyDepartment of Materials Science and Engineering, The Pennsylvania State University, University Park, Pennsylvania. Electronic address: rhc@plmsc.psu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A monoclonal antibody solution displays an increase in low shear rate viscosity upon aggregation after prolonged incubation at 40°C. The morphology and interactions leading to the formation of the aggregates responsible for this non-Newtonian character are resolved using small-angle neutron scattering. Our data show a weak repulsive barrier before proteins aggregate reversibly, unless a favorable contact with high binding energy occurs. Two types of aggregates were identified after incubation at 40°C: oligomers with radius of gyration ∼10 nm and fractal submicrometer particles formed by a slow reaction-limited aggregation process, consistent with monomers colliding many times before finding a favorable strong interaction site. Before incubation, these antibody solutions are Newtonian liquids with no increase in low shear rate viscosity and no upturn in scattering at low wavevector, whereas aggregated solutions under the same conditions have both of these features. These results demonstrate that fractal submicrometer particles are responsible for the increase in low shear rate viscosity and low wavevector upturn in scattered intensity of aggregated antibody solutions; both are removed from aggregated samples by filtering.

Indexed as

Protein AggregatesAntibodies, MonoclonalHumansImmunoglobulin GNeutron DiffractionScattering, Small AngleAntibodies, MonoclonalImmunoglobulin GProtein Aggregates

Identifiers

PMID25028888
PMCPMC4104057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.